Table 3.
Cox regression model of predictors of end of follow-up virological suppression (n = 741)
| Covariates |
Multivariable |
|
| Hazard ratio (95%CI) | P value | |
| Baseline HBV DNA (log10 IU/mL) | 0.897 (0.833-0.967) | 0.0046 |
| HBeAg status (HBeAg pos vs neg) | 0.373 (0.183-0.762) | 0.0069 |
| Treatment experience (Naïve vs experienced) | 1.189 (0.598-2.364) | 0.6207 |
| Age (yr) | 1.018 (0.992-1.044) | 0.1760 |
| ALT (log10 IU/mL) | 1.093 (0.816-1.465) | 0.5505 |
1
Excludes patients who were not viraemic at baseline. HBV: Hepatitis B virus; ALT: Alanine aminotransferase.